Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]

New important compounds for targeted and immunotherapies for lung cancer

Dr Christian Rolfo - Univeristy of Maryland, Baltimore, USA

New important compounds for targeted and immunotherapies for lung cancer ( Dr Christian Rolfo - Univeristy of Maryland, Baltimore, USA )

Updates from a range of lung cancer studies

Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA

Updates from a range of lung cancer studies ( Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA )

Rare mutations in non small cell lung cancer

Dr Tom Stinchcombe - Duke Cancer Institute, Durham, USA

Rare mutations in non small cell lung cancer ( Dr Tom Stinchcombe - Duke Cancer Institute, Durham, USA )

Several important studies for lung cancer

Prof Luis Raez - Herbert Wertheim College of Medicine, Miami, USA

Several important studies for lung cancer ( Prof Luis Raez - Herbert Wertheim College of Medicine, Miami, USA )

Key advances in ALL and AML

Dr Martin S. Tallman - Moffitt Cancer Center, Tampa, USA

Key advances in ALL and AML ( Dr Martin S. Tallman - Moffitt Cancer Center, Tampa, USA )

Extended genetic testing and GYN cancer risk

Dr Zoe Kemp - The Royal Marsden NHS Foundation Trust, London, UK

Extended genetic testing and GYN cancer risk ( Dr Zoe Kemp - The Royal Marsden NHS Foundation Trust, London, UK )

Gynaecology highlights from ASCO 2018

Prof Christina Fotopoulou - Imperial College London Healthcare Trust, London, UK

Gynaecology highlights from ASCO 2018 ( Prof Christina Fotopoulou - Imperial College London Healthcare Trust, London, UK )

ASCO highlights: Bevacizumab for relapsed ovarian cancer

Prof Jonathan Ledermann - University College London Hospitals, London, UK

ASCO highlights: Bevacizumab for relapsed ovarian cancer ( Prof Jonathan Ledermann - University College London Hospitals, London, UK )

Unexpected role for Immuno-oncology in SCCOHT

Dr Douglas Levine - NYU Langone Medical Center, New York, USA

Unexpected role for Immuno-oncology in SCCOHT ( Dr Douglas Levine - NYU Langone Medical Center, New York, USA )

IG rearrangement, JAK1/2 inhibition and aggressive B-cell lymphoma development...

Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna...

IG rearrangement, JAK1/2 inhibition and aggressive B-cell lymphoma development... ( Prof Veronika Sexl - University of Veterinary Medicine of Vienna, Vienna, Austria )

The TAPUR trial family: a global data sharing platform

Dr Richard Schilsky - American Society Of Clinical Oncology, USA

The TAPUR trial family: a global data sharing platform ( Dr Richard Schilsky - American Society Of Clinical Oncology, USA )

Biobanking and early diagnosis to defeat NSCLC

Dr Amir Onn - Chaim Sheba Medical Center, Ramat Gan, Israel

Biobanking and early diagnosis to defeat NSCLC ( Dr Amir Onn - Chaim Sheba Medical Center, Ramat Gan, Israel )

More from ecancer